Alto Neuroscience (ANRO) earnings history

Alto Neuroscience's most recent results in the table are for Q2 2025, reported on August 13, 2025. The company posted a loss of $0.65 per share, wider than the $0.60 loss analysts expected, a miss of 8.59%. A year earlier, in Q2 2024, the loss was $0.60 per share, so the quarterly loss widened by about 8%. No revenue figures or revenue estimates are given for any quarter.

The record here is short: four quarters, Q2 2024, Q4 2024, Q1 2025 and Q2 2025, with no row for Q3 2024. Every quarter shown is a loss, ranging from $0.52 per share in Q4 2024 to $0.65 in Q2 2025. The loss has widened in each quarter since Q4 2024, from $0.52 to $0.56 and then $0.65. Alto beat the EPS estimate three times out of four, by 19.48% in Q4 2024, 8.63% in Q2 2024 and 7.99% in Q1 2025. There are too few quarters for full-year totals.

The table ends at Q2 2025 and has no later quarter. Past report dates fell in late March, mid-May and mid-August. When newer quarters are added, they will show whether the per-share loss kept widening or eased.